Mangrove Partners has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $642 Million distributed in 154 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $42.6M, Enova International, Inc. with a value of $39.8M, Liberty Broadband Corp with a value of $37.9M, Laureate Education, Inc. with a value of $35.3M, and Aer Cap Holdings N.V. with a value of $32.6M.

Examining the 13F form we can see an decrease of $128M in the current position value, from $769M to 642M.

Mangrove Partners is based out at New York, NY

Below you can find more details about Mangrove Partners portfolio as well as his latest detailed transactions.

Portfolio value $642 Million
Healthcare: $151 Million
Financial Services: $109 Million
Technology: $82.6 Million
Communication Services: $61.6 Million
Consumer Defensive: $58.7 Million
Consumer Cyclical: $51.7 Million
Industrials: $41.8 Million
ETFs: $26 Million
Other: $59 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 154
  • Current Value $642 Million
  • Prior Value $769 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 72 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 36 stocks
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.